Sword Diagnostics

About:

Sword Diagnostics is a life sciences company addressing the needs of the research, pharmaceutical, and clinical communities.

Website: http://www.sworddiagnostics.com

Top Investors: Avant Global, Keiretsu Forum Northwest, NJTC Venture Fund, Jumpstart New Jersey Angel Network

Description:

Sword Diagnostics is a leading-edge life sciences company created in response to the rapidly evolving needs of the research, pharmaceutical, and clinical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and diseased-related biological processes, today's life science tools are unable to effectively measure, quantify, and determine the ultimate value of these biological markers. Sword Diagnostics' technology is directly aimed at making it easier to understand these newly emerging biomarkers, as well as extending the utility of existing diagnostics assays.

Total Funding Amount:

$5.45M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Carmel, Indiana, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)sworddiagnostics.com

Founders:

David Dingott

Number of Employees:

1-10

Last Funding Date:

2017-11-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai